4-112904566-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The ENST00000683180.1(ANK2):n.255G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000614 in 1,332,444 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0029 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00032 ( 0 hom. )
Consequence
ANK2
ENST00000683180.1 non_coding_transcript_exon
ENST00000683180.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.828
Publications
0 publications found
Genes affected
ANK2 (HGNC:493): (ankyrin 2) This gene encodes a member of the ankyrin family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton. Ankyrins play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. The protein encoded by this gene is required for targeting and stability of Na/Ca exchanger 1 in cardiomyocytes. Mutations in this gene cause long QT syndrome 4 and cardiac arrhythmia syndrome. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Dec 2011]
ANK2 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
- Brugada syndromeInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen
- catecholaminergic polymorphic ventricular tachycardiaInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
- heart conduction diseaseInheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
- neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: G2P
- cardiac arrhythmia, ankyrin-B-relatedInheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- long QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 4-112904566-G-A is Benign according to our data. Variant chr4-112904566-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1200065.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00293 (446/152148) while in subpopulation AFR AF = 0.0104 (430/41534). AF 95% confidence interval is 0.00955. There are 1 homozygotes in GnomAd4. There are 209 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 446 AD,Unknown gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANK2 | NM_001386142.1 | c.21+52G>A | intron_variant | Intron 2 of 44 | NP_001373071.1 | |||
ANK2 | NM_001386143.1 | c.21+52G>A | intron_variant | Intron 2 of 47 | NP_001373072.1 | |||
ANK2 | NM_001386186.2 | c.72+198349G>A | intron_variant | Intron 1 of 46 | NP_001373115.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANK2 | ENST00000506722.5 | c.21+52G>A | intron_variant | Intron 2 of 46 | 1 | ENSP00000421067.1 | ||||
ANK2 | ENST00000683180.1 | n.255G>A | non_coding_transcript_exon_variant | Exon 2 of 2 | ||||||
ANK2 | ENST00000672209.1 | c.21+52G>A | intron_variant | Intron 2 of 47 | ENSP00000499982.1 |
Frequencies
GnomAD3 genomes AF: 0.00293 AC: 446AN: 152030Hom.: 1 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
446
AN:
152030
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000315 AC: 372AN: 1180296Hom.: 0 AF XY: 0.000282 AC XY: 166AN XY: 588866 show subpopulations
GnomAD4 exome
AF:
AC:
372
AN:
1180296
Hom.:
AF XY:
AC XY:
166
AN XY:
588866
show subpopulations
African (AFR)
AF:
AC:
268
AN:
25132
American (AMR)
AF:
AC:
26
AN:
24954
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
22894
East Asian (EAS)
AF:
AC:
0
AN:
32852
South Asian (SAS)
AF:
AC:
2
AN:
64764
European-Finnish (FIN)
AF:
AC:
1
AN:
48430
Middle Eastern (MID)
AF:
AC:
2
AN:
5254
European-Non Finnish (NFE)
AF:
AC:
44
AN:
905728
Other (OTH)
AF:
AC:
29
AN:
50288
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00293 AC: 446AN: 152148Hom.: 1 Cov.: 33 AF XY: 0.00281 AC XY: 209AN XY: 74398 show subpopulations
GnomAD4 genome
AF:
AC:
446
AN:
152148
Hom.:
Cov.:
33
AF XY:
AC XY:
209
AN XY:
74398
show subpopulations
African (AFR)
AF:
AC:
430
AN:
41534
American (AMR)
AF:
AC:
11
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5180
South Asian (SAS)
AF:
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
AC:
0
AN:
10588
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2
AN:
67960
Other (OTH)
AF:
AC:
3
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
21
42
62
83
104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3438
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jul 17, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.